(g)
whether the sponsor has obtained an orphan designation for the investigational medicinal product for an orphan condition;
← anx_I__cpt_2__point_7__point_f__text_1 · All articles · anx_I__cpt_2__point_7__point_g__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.